Hemagglutinin (HA)

Hemagglutinin (HA) Overview

English NameInfluenza virus hemagglutinin glycoproteinsApproved Drugs0
Drugs in Clinical Trials3Target SynonymHemagglutinin,HA,Hemagglutinin Glycoproteins, Influenza Virus
Highest Development StagePhase 1 Clinical
English NameInfluenza virus hemagglutinin glycoproteins
Target SynonymHemagglutinin,HA,Hemagglutinin Glycoproteins, Influenza Virus
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 1 Clinical

Hemagglutinin (HA) Product List

  • Product Category

    Kits (1)

  • Product Status

    Launched (1)

  • Species

    Influenza (A/Wisconsin/67/2022) (1)

  • Tag

    - (1)

  • Conjugate

    - (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
RAS-T226
Influenza (A/Wisconsin/67/2022)
-
Mouse Anti-Influenza (A/Wisconsin/67/2022) Antibody IgG Titer ELISA Assay Kit (HA)
Total: 1
  • 1

Hemagglutinin (HA) Synonyms

HA,Hemagglutinin

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Anti-influenza monoclonal antibody (AIMM Therapeutics)Phase 1 ClinicalAimm TherapeuticsInfluenza, Human
Details
cH8/1N1 LAIVPhase 1 ClinicalIcahn School Of Medicine At Mount SinaiInfluenza, Human
Details
Ad4-H5-Vtn (Emergent BioSolutions/National Institute of Allergy and Infectious Diseases)Phase 1 ClinicalEmergent Biosolutions IncCommunicable Diseases
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland